This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Derecola, A.
Right arrow Articles by Poupard, J. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Derecola, A.
Right arrow Articles by Poupard, J. A.

 Previous Article  |  Next Article 

Antimicrobial Agents and Chemotherapy, January 1999, p. 185-186, Vol. 43, No. 1
0066-4804/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.

A 5-Year Surveillance Study of 44,691 Isolates of Haemophilus influenzae Project Beta-Alert 1993-1997

A. Derecola,1,* D. L. Butler,1 R. L. Kaplan,2 L. A. Miller,1 and J. A. Poupard1

Department of Anti-Infectives, SmithKline Beecham Pharmaceuticals, Collegeville, Pennsylvania,1 and SmithKline Beecham Clinical Laboratories, Atlanta, Georgia2

Received 19 June 1998/Returned for modification 13 August 1998/Accepted 14 October 1998

Beta-Alert is a surveillance program developed in 1993 to monitor the percentage of beta -lactamase-producing Haemophilus influenzae isolates obtained from specimens submitted to regional commercial laboratories. The results of this study demonstrate that levels of beta -lactamase producers have remained between 31 and 38% in the United States over the past 5 years.

* Corresponding author. Mailing address: SmithKline Beecham Pharmaceuticals, 1250 S. Collegeville Rd., UP1340, P.O. Box 5089, Collegeville, PA 19426-0989. Phone: (610) 917-7391. Fax: (610) 917-4617. E-mail: ann_m_derecola{at}sbphrd.com.

Antimicrobial Agents and Chemotherapy, January 1999, p. 185-186, Vol. 43, No. 1
0066-4804/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.


This article has been cited by other articles:

  • Heilmann, K. P., Rice, C. L., Miller, A. L., Miller, N. J., Beekmann, S. E., Pfaller, M. A., Richter, S. S., Doern, G. V. (2005). Decreasing Prevalence of {beta}-Lactamase Production among Respiratory Tract Isolates of Haemophilus influenzae in the United States. Antimicrob. Agents Chemother. 49: 2561-2564 [Abstract] [Full Text]  
  • Kyd, J. M., Cripps, A. W., Novotny, L. A., Bakaletz, L. O. (2003). Efficacy of the 26-Kilodalton Outer Membrane Protein and Two P5 Fimbrin-Derived Immunogens To Induce Clearance of Nontypeable Haemophilus influenzae from the Rat Middle Ear and Lungs as Well as from the Chinchilla Middle Ear and Nasopharynx. Infect. Immun. 71: 4691-4699 [Abstract] [Full Text]  
  • Hsueh, P.-R., Liu, Y.-C., Shyr, J.-M., Wu, T.-L., Yan, J.-J., Wu, J.-J., Leu, H.-S., Chuang, Y.-C., Yeu-Jen Lau, , Luh, K.-T. (2000). Multicenter Surveillance of Antimicrobial Resistance of Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis in Taiwan during the 1998-1999 Respiratory Season. Antimicrob. Agents Chemother. 44: 1342-1345 [Abstract] [Full Text]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»